Antibiotics

It is produced by the strain of Penicillium notatum NRRL 1209, Pen. chrysogenum NRRL 1951. It is an antibiotic.

Peptaibolin is produced by the strain of Sepedonium sp. HKI-0117, Sepedonium ampullosporum HKI-0053. It has anti-gram-positive bacteria and yeast activity, but the antibacterial activity is weak. It inhibits candida albicans with the MIC of 100 μg/mL.

It is produced by the strain of Bacillus circulans AJ 3902. It's a peptide antibiotic. It has anti-gram-negative bacteria, gram-positive bacteria and anaerobic bacteria activity.

It is produced by the strain of Str. sp. HIL Y-9031725. It has weak anti-gram-positive bacterial effect, but also has inhibitory effect against physiologically important enzyme like renin (IC50 is 440 μg/mL).

It is produced by the strain of Str. violaceoniger AB 9991-80, Str. violaceoniger AB 1047T-33. It has effect against anaerobic bacteria.

It is produced by the strain of Str. violaceoniger AB 9991-80, Str. violaceoniger AB 1047T-33. It has effect against anaerobic bacteria.

It is produced by the strain of Str. violaceoniger AB 9991-80, Str. violaceoniger AB 1047T-33. It has effect against anaerobic bacteria.

It is produced by the strain of Str. violaceoniger AB 9991-80, Str. violaceoniger AB 1047T-33. It has effect against anaerobic bacteria.

It is produced by the strain of Streptoverticillium verticillum 843-1. It's a heteropeptide antibiotic. It has anti-gram-positive bacteria, negative bacteria and mycobacterium effects. It extends the survival time of mice transplanted with Ehrman's ascites cancer by 300 percent with MED of 12.5-25 μg/mL. It inhibits airy entity carcinoma in mice with IC50 of 0.31 μg/mL.

It is produced by the strain of Streptoverticillium verticillum 843-1. It's a heteropeptide antibiotic. It has anti-gram-positive bacteria, negative bacteria and mycobacterium effects. It extends the survival time of mice transplanted with Ehrman's ascites cancer by 300 percent with MED of 25-50 μg/mL.

It is produced by the strain of Str. nigrescens. The main component E has weak effect against gram-positive bacteria, but has strong effect against fungi. Its antimicrobial activity is similar to Phoslactomycin E.

It is produced by the strain of Str. nigrescens. The main component E has weak effect against gram-positive bacteria, but has strong effect against fungi. Its antimicrobial activity is similar to Phoslactomycin E.

It is produced by the strain of Str. nigrescens. The main component E has weak effect against gram-positive bacteria, but has strong effect against fungi. Its antimicrobial activity is similar to Phoslactomycin E.

It is produced by the strain of Str. nigrescens. The main component E has weak effect against gram-positive bacteria, but has strong effect against fungi. Its antimicrobial activity is similar to Phoslactomycin E.

It is produced by the strain of Str. nigrescens. It is the main component, which has weak effect against gram-positive bacteria, but has strong effect against fungi.

It is produced by the strain of Str. nigrescens. The main component E has weak effect against gram-positive bacteria, but has strong effect against fungi. Its antimicrobial activity is similar to Phoslactomycin E.

It is produced by the strain of Str. sp. RK-16. It can inhibit the cell cycle progression and cell morphology recovery of srcts-NRK cells. It has antifungal effect.

It is produced by the strain of Str. sp. RK-16. It can inhibit the cell cycle progression and cell morphology recovery of srcts-NRK cells.

It is produced by the strain of Phyllosticta sp. pH-A. It's an antifungal antibiotic. It has the same effect as Sphaeropsidin and Epoxydon.

It is produced by the strain of Str. mobaraensis 16-24. It has anti-fungal, gram-positive bacteria and insect effects, but also has weak anti-gram-negative bacteria effect.